Transfusion-Associated Infections Immunohematology Review 471
INFECTION PREVENTION COMMENTS
HIV
Hepatitis B
Hepatitis C
HTLV-I and -II
Syphilis
Malaria
Babesiosis
Chagas’ disease
Cytomegalovirus
Estimated risk: 1 in 1,467,000 transfusions. With NAT,
window period 9 days.
Estimated risk: 1 in 280,000 transfusions.
Estimated risk: 1 in 1,149,000 transfusions. With NAT,
window period 7.4 days.
Rare in U.S.
Limited risk in refrigerated or frozen components. Spiro-
chetes can’t survive in cold. Highest risk from platelets.
Plasmodiumis transmitted in RBCs.
Babesiais transmitted in RBCs.
Trypanosoma cruziis transmitted in blood. Potential risk
in donors from Central & S. America.
CMV transmitted in WBCs. Risk to CMV-neg immunocom-
promised pts & premature infants of CMV-neg mothers.
Donor testing
Donor testing
Donor testing
Donor testing
Donor testing
Donor history
Donor history
Donor history
Selected donor testing (not routine). Use of CMV-neg
or leukoreduced components for pts at risk.
continued...